Searched for
QUARKPHARMA
Biocon, Quark get DCGI nod for trials of new eye disease drugBiocon Chairperson Kiran Mazumdar Shaw said, "India has a significant number of NAION patients and we are pleased to be the first one to pr...- Biocon shares soar 12 pc as co inks pact with Quark PharmaBiocon's scrip ended the day at Rs 437.35, a gain of 11.38% on the BSE. During the day, the scrip surged 14.83% to Rs 450.90 -- its 52-week...
- Biocon inks licensing pact with US-based Quark PharmaBiocon today said it has inked a pact with Quark Pharmaceuticals, Inc to develop a range of siRNA (small interfering RNA) based novel thera...
- Load More